8 mg/dl, hypoproteinemia and hypoalbuminemia, increased transaminases (aspartate transaminase (AST) and alanine transaminase (ALT)), procalcitonin (PCT), decreased prothrombin time (PT), international normalised ratio (INR), activated partial thromboplastin time (aPTT), fibrinogen of 633 mg/dl, and markedly decreased antithrombin III (Table 2). This evidence concerns the gene GPT and Hypoalbuminemia.